Neuralstem Announces Issuance of New Patent Covering Broad Therapeutic Use of Neural Stem Cells

Neuralstem Reports First Quarter 2019 Fiscal Results

Neuralstem Appoints David J. Mazzo, Ph.D., to Board of Directors

Neuralstem Reports Year End 2018 Fiscal Results

Neuralstem to Expand Pipeline as Part of Aggressive Growth Effort

Neuralstem Appoints Ken Carter, Ph.D., as Executive Chairman of the Board

Neuralstem Reports Third Quarter 2018 Financial Results and Provides Business Update

Neuralstem Announces $2.1 Million Registered Direct Offering

Neuralstem Announces Publication of a Study Showing Benefits of Neural Stem Cell (NSC) Transplantation in a Mouse Model of Alzheimer’s Disease

Neuralstem Provides Business Update and Reports Second Quarter 2018 Fiscal Results